Hakamifard et al., Immunopathologia Persa,
doi:10.34172/ipp.2021.xx (Peer Reviewed)
The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial
RCT with 38 patients treated with vitamin C and vitamin E, and 34 control patients, showing lower ICU admission with treatment, but not statistically significant.
Hakamifard et al., 4/14/2021, Randomized Controlled Trial, Iran, Middle East, peer-reviewed, 8 authors, this trial uses multiple treatments in the treatment arm (combined with vitamin E) - results of individual treatments may vary.
risk of ICU admission, 46.3% lower, RR 0.54, p = 0.46, treatment 3 of 38 (7.9%), control 5 of 34 (14.7%).
hospitalization time, 1.0% lower, relative time 0.99, p = 0.82, treatment 38, control 34.
Effect extraction follows
pre-specified rules
prioritizing more serious outcomes. For an individual study the most serious
outcome may have a smaller number of events and lower statistical signficance,
however this provides the strongest evidence for the most serious outcomes
when combining the results of many trials.